Early Phase Cancer Immunotherapy (Hardcover, 1st ed. 2018)
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
R5,009
List Price R5,491
Save R482 9%
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
50090
@R469pm x 12* 
Ships in 12 - 17 working days
Add to wish listReview this Item
Donate to Against Period Poverty
Product Description
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Customer Reviews
No reviews or ratings yet - be the first to create one!
Product Details
General
Imprint | Springer International Publishing AG |
Country of origin | Switzerland |
Series | Current Cancer Research |
Release date | November 2017 |
Availability | Expected to ship within 12 - 17 working days |
First published | 2018 |
Editors | Sandip Pravin Patel, Razelle Kurzrock |
Dimensions | 235 x 155mm (L x W) |
Format | Hardcover |
Pages | 331 |
Edition | 1st ed. 2018 |
ISBN-13 | 978-3-319-63756-3 |
Barcode | 9783319637563 |
Categories | |
LSN | 3-319-63756-8 |
Similar Products | Recommended ProductsSee more 
Trending On Loot
Be the first to know about our
latest deals & promos! Subscribe Now
